1. Furanocoumarin Content, Antioxidant Activity, and Inhibitory Potential of Heracleum verticillatum, Heracleum sibiricum, Heracleum angustisectum, and Heracleum ternatum Extracts against Enzymes Involved in Alzheimer's Disease and Type II Diabetes.
- Author
-
Ozek G, Yur S, Goger F, Ozek T, Andjelkovic B, Godjevac D, Sofrenic I, Aneva I, Todorova M, and Trendafilova A
- Subjects
- Acetylcholinesterase metabolism, Alzheimer Disease drug therapy, Alzheimer Disease metabolism, Animals, Antioxidants chemical synthesis, Antioxidants chemistry, Diabetes Mellitus, Type 2 drug therapy, Electrophorus, Enzyme Inhibitors chemical synthesis, Enzyme Inhibitors chemistry, Furocoumarins chemical synthesis, Furocoumarins chemistry, Humans, Hypoglycemic Agents chemical synthesis, Hypoglycemic Agents chemistry, Plant Extracts chemistry, Plant Extracts isolation & purification, Plant Extracts pharmacology, Swine, alpha-Amylases antagonists & inhibitors, alpha-Amylases metabolism, Antioxidants pharmacology, Biphenyl Compounds antagonists & inhibitors, Enzyme Inhibitors pharmacology, Furocoumarins pharmacology, Heracleum chemistry, Hypoglycemic Agents pharmacology, Picrates antagonists & inhibitors
- Abstract
Hexane extracts of Heracleum verticillatum, H. sibiricum, H. angustisectum, and H. ternatum were studied for their furanocoumarin content antioxidant potential and acetylcholinesterase and α-amylase inhibitory activities. Quantification of the furanocoumarins was performed by
1 H-NMR. Pimpinellin was found to be the main component in the roots of all studied species. Bergapten and imperatorin were the major compounds in the fruits of H. sibiricum and H. verticillatum, respectively, while byakangelicol dominated in H. angustisectum and H. ternatum fruits. The leaf and fruit extracts of H. angustisectum demonstrated the highest DPPH radical scavenging activity and TEAC (IC50 0.58 mg/mL and 1.83 mm, respectively). The root extracts of H. verticillatum and H. angustisectum were found to be the most effective against acetylcholinesterase (IC50 0.30 and 0.34 mg/mL, respectively). The studied extracts were not active or demonstrated a weak inhibitory effect (%Inh. up to 29.7) towards α-amylase., (© 2019 Wiley-VHCA AG, Zurich, Switzerland.)- Published
- 2019
- Full Text
- View/download PDF